[Isolation and identification of Streptococcus suis serotype 2 from sick-pig samples of Sichuan province].

Streptococcus suis serotype 2 (SS2) is a major pathogen frequently associated with infections in pigs. There are presently 35 serotypes of S.suis (serotype 1 to 34 and serotype 1/2) recognized on the basis of capsular antigens. Few people were reported to infect with SS2 in the past years. However, an accidental case happened in Sichuan province of China in 2005. Some people got ill and died, and all of them were closely contacted with sick pigs. Based on clinical features and epidemiologic data, this case could be caused by SS2 infection. Liver, spleen, kidney, lung and serum samples were collected and used for pathogen isolation and identification in laboratory, three strain bacteria were isolated. The three strains of SS2 showed typical morphology of SS2 on blood agar and under microscope with Gram stain. They were also agglutinated with standard serum of SS2. Biochemical characteristics of the three bacteria were tested using API 20 strep and analyzed by API software (version 3.3), results showed they were SS2. Four pairs of primer were designed, which were exactly matched the extracellular factor gene, muraminidase released protein gene, capsular polysaccharides gene and 16S rRNA gene respectively. These primers were used on polymerase chain reaction (PCR), and the PCR products were 626bp, 885bp, 487bp and 297bp on agarose gel, respectively. Drug sensitivity test were also done and results showed that they were sensitive to cefazolin, clindamycin, erythromycin, levofloxacin, nitrofurantoin, penicillin-G, and vancomycin and resistive to tetracycline. Balb/c mice infected with the isolated SS2 strain showed swelling in stomach and intestine, cyanochroia at mouth and suggillation under skin, which were similar to the clinical features of patients. Streptococcus suis serotype 2 were also found on lung sheeting sample under microscope with Gram stain. Rabbits infected with the isolated SS2 showed the similar clinical features with mice.

Preparation, characterization and pharmacokinetics of doxycycline hydrochloride and florfenicol polyvinylpyrroliddone microparticle entrapped with hydroxypropyl-ß-cyclodextrin inclusion complexes suspension.

In order to effectively control the bacterial pneumonia in pigs, doxycycline hydrochloride (DoxHcl) and florfenicol (FF) microparticle suspension together with inclusion complexes was prepared by using hydroxypropyl-ß-cyclodextrin (HP-ß-CD) as host molecules, polyvinylpyrroliddone (PVP) as polymer carriers and hydroxypropyl methyl cellulose (HPMC) as suspending agents. In vitro antibacterial activity, properties, stability and pharmacokinetics of the suspension were studied. The results demonstrated that DoxHcl and FF had a synergistic or additive antibacterial activity against Streptococcus suis, Actinobacillus pleuropneumoniae and Haemophilus parasuis. The size, polydispersity index and zeta potential of microparticles were 1.46 ± 0.06 µm, 0.30 ± 0.02 and 1.53 ± 0.04 mV, respectively. The encapsulation efficiency (EE) of DoxHcl and FF was 45.28% ± 3.30% and 89.69% ± 2.71%, respectively. The re-dispersed time and sedimentation rate of the suspension were 1 min and 1. The suspension went through the 9-gage needle smoothly with withdrawal volume of 9.12 ± 0.87 mL/min. The suspension showed good stability when stored away from light, no irritation at the injection site and sustained release in PBS buffer. After intramuscular administration to pig, DoxHcl and FF could maintain over 0.15 µg/mL for 72 h. Compared to the control injection, the suspension increased the elimination half-life (T½ke) as well as mean residence time (MRT) of DoxHcl from 5.73 to 9.77 h and from 12.02 to 18.81 h, and those of FF from 12.02 to 26.19 h and from 12.02 to 28.16 h, respectively. The suspension increased the bioavailability of DoxHcl and FF by 1.74 and 1.13-fold, respectively. These results suggest that the compound suspension is a promising formulation for pig pneumonia therapy.

Effects of cello-oligosaccharide on intestinal microbiota and epithelial barrier function of weanling pigs.

A total of 144 piglets (Duroc × Landrace × Yorkshire; average initial weight of 6.13 kg weaned at 21 ± 1 d age) were allotted to 4 treatments for 2 wk, each of which had 6 pens with 6 pigs per pen. After the feeding experiment, 6 pigs per treatment were slaughtered to investigate the effects of cello-oligosaccharide (COS) on intestinal microbiota and epithelial barrier function. The COS was added to the basal diet at 0, 1.5, 3.0, and 4.5 g/kg diet at the expense of corn, respectively. Plasma -lactate, diamine oxidase (DAO), and the Ussing chamber technique were used to determine the intestinal barrier function. 16S rRNA-based methods were used for intestinal microbiota analysis. The results showed that incremental levels of COS had no effect ( > 0.05) on growth performance. Incremental levels of COS increased lactobacilli in jejunal and colonic contents ( < 0.05); decreased in jejunal contents ( < 0.05) and and in colonic contents ( < 0.05); reduced plasma DAO (linear, = 0.013, and quadratic, = 0.037); increased jejunal mucosa DAO (linear, = 0.003, and quadratic, = 0.008); decreased fluorescein isothiocyanate dextran 4 kDa flux of jejunum and colon ( < 0.05); and increased transepithelial electrical resistance (TER) in colon ( < 0.05), claudin-1 protein expression in jejunal mucosa (linear, = 0.001, and quadratic, = 0.003), and protein expressions of claudin-1 and zonula occludens-1 (ZO-1) in colonic mucosa linearly ( = 0.001 and = 0.001, respectively) and quadratically ( = 0.001 and = 0.002, respectively). The results indicated that the improved microbial ecosystem in the presence of COS might contribute to improvement in intestinal barrier function and tight junction proteins. Results also showed that the appropriate dietary COS supplementation level was 3.0 g/kg in weaned pig diets under our trial conditions.